University of Colorado School of Medicine Will Work with DreaMed Diabetes to Deploy Its Advisor System as a New Resource for Diabetes Device Initiation
Retrieved on:
Wednesday, January 26, 2022
Research, Pharmaceutical, Data Management, Technology, Medical Devices, Hospitals, University, Education, Science, Biotechnology, Practice Management, Health, Diabetes, University, University of Colorado, Colorado School of Public Health, Education, Anschutz Medical Campus, Skaggs School of Pharmacy, Patient, SEEDS, Pregnancy, Income, University of Colorado School of Medicine, Pharmacy, Dream House for Medically Fragile Children, Medtronic, FDA, Multimedia, Research, American Association of Clinical Endocrinologists, Adult, Geography, Leona, Endocrinology, Solution, Technology, USC School of Pharmacy, Goal, Autoimmunity, Physician, Blood, Partnership, BDC, Pharmaceutical industry, Medicine, Diabetes, Barbara Davis Center for Diabetes at University of Colorado School of Medicine, DreaMed Diabetes, BARBARA DAVIS CENTER FOR DIABETES AT UNIVERSITY OF COLORADO SCHOOL OF MEDICINE, DREAMED DIABETES
Dr. Messer will work with DreaMed to expand the DreaMed clinical decision support platform to support patients and care providers in the primary care setting.
Key Points:
- Dr. Messer will work with DreaMed to expand the DreaMed clinical decision support platform to support patients and care providers in the primary care setting.
- There are various types of diabetes technologies that can help people with diabetes, Messer says.
- The center is part of the University of Colorado School of Medicine on the Anschutz Medical Campus , one of four campuses in the University of Colorado system.
- Since then, DreaMed Diabetes has been vigorously working on the DreaMed Advisor portfolio, decision support tools in diabetes management.